Bank Julius Baer & Co’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.95K | Buy |
810
+64
| +9% | +$154 | ﹤0.01% | 599 |
|
|
2025
Q1 | $1.86K | Buy |
746
+22
| +3% | +$55 | ﹤0.01% | 600 |
|
|
2024
Q4 | $4.35K | Buy |
724
+49
| +7% | +$295 | ﹤0.01% | 613 |
|
|
2024
Q3 | $6.65K | Sell |
675
-27
| -4% | -$266 | ﹤0.01% | 500 |
|
|
2024
Q2 | $5.59K | Sell |
702
-88
| -11% | -$701 | ﹤0.01% | 481 |
|
|
2024
Q1 | $6.85K | Sell |
790
-21
| -3% | -$182 | ﹤0.01% | 517 |
|
|
2023
Q4 | $5.31K | Sell |
811
-208,838
| -100% | -$1.37M | ﹤0.01% | 533 |
|
|
2023
Q3 | $2.1M | Sell |
209,649
-3,971
| -2% | -$39.7K | 0.01% | 205 |
|
|
2023
Q2 | $2.66M | Sell |
213,620
-5,560
| -3% | -$69.1K | 0.02% | 197 |
|
|
2023
Q1 | $3.07M | Sell |
219,180
-3,122
| -1% | -$43.7K | 0.02% | 193 |
|
|
2022
Q4 | $3.18M | Buy |
222,302
+7,518
| +4% | +$108K | 0.02% | 195 |
|
|
2022
Q3 | $5.48M | Buy |
214,784
+1,138
| +0.5% | +$29.1K | 0.04% | 160 |
|
|
2022
Q2 | $6.07M | Buy |
213,646
+69,570
| +48% | +$1.98M | 0.04% | 165 |
|
|
2022
Q1 | $5.08M | Sell |
144,076
-7,148
| -5% | -$252K | 0.03% | 174 |
|
|
2021
Q4 | $6.34M | Buy |
151,224
+18,572
| +14% | +$778K | 0.03% | 185 |
|
|
2021
Q3 | $6.51M | Buy |
132,652
+48,923
| +58% | +$2.4M | 0.04% | 185 |
|
|
2021
Q2 | $3.49M | Buy |
+83,729
| New | +$3.49M | 0.02% | 233 |
|